Table 2.
Zone of inhibition diameter formed by CFS and cur-CFS against pathogenic bacteria Shigella dysenteriyae, Staphylococ aureus, Klebsiella pneumoniae, Salmonella typhi, and Pseudomonas aeruginosa.
| Strain | Supernatant type | Diameter (mm) |
|---|---|---|
| Staphylococ aureus | CFS | 7.14 ± 0.2 |
| cur-CFS | 13.2 ± 0.3 | |
| CFS + PK | 0.00 ± 0.0 | |
| cur-CFS + PK | 0.00 ± 0.0 | |
| Positive control (Azithromycin) | 20.6 ± 0.3 | |
| Negative control (PBS) | 0.00 ± 0.0 | |
| Salmonella typhi | CFS | 8.15 ± 0.3 |
| cur-CFS | 10.9 ± 0.3 | |
| CFS + PK | 0.00 ± 0.0 | |
| cur-CFS + PK | 0.00 ± 0.0 | |
| Positive control (Azithromycin) | 20.5 ± 0.4 | |
| Negative control (PBS) | 0.00 ± 0.0 | |
| Pseudomonas aeruginosa | CFS | 8.12 ± 0.4 |
| cur-CFS | 13.2 ± 0.4 | |
| CFS + PK | 0.00 ± 0.0 | |
| cur-CFS + PK | 0.00 ± 0.0 | |
| Positive control (Azithromycin) | 20.4 ± 0.2 | |
| Negative control (PBS) | 0.00 ± 0.0 | |
| Shigella dysenteriyae | CFS | 7.40 ± 0.2 |
| cur-CFS | 15.3 ± 0.4 | |
| CFS + PK | 0.00 ± 0.0 | |
| cur-CFS + PK | 0.00 ± 0.0 | |
| Positive control (Azithromycin) | 23.5 ± 0.4 | |
| Negative control (PBS) | 0.00 ± 0.0 | |
| Klebsiella pneumonia | CFS | 7.20 ± 0.2 |
| cur-CFS | 12.2 ± 0.3 | |
| CFS + PK | 0.00 ± 0.0 | |
| cur-CFS + PK | 0.00 ± 0.0 | |
| 30.8 ± 0.3 | ||
| Positive control (tetracycline) | ||
| Negative control (PBS) | 0.00 ± 0.0 |